Deep Learning techniques to detect and analysis of multiple sclerosis through MRI: A systematic literature review

被引：1

作者：

Belwal, Priyanka ^{[1
]}

Singh, Surendra ^{[1
]}

机构：

[1] Department of Computer Science and Engineering, NIT Uttarakhand

来源：

Computers in Biology and Medicine | 2025年 / 185卷

关键词：

Classification; CNN; Deep Learning; Detection; MRI; Multiple sclerosis; Segmentation;

D O I：

10.1016/j.compbiomed.2024.109530

中图分类号：

学科分类号：

摘要：

Deep learning (DL) techniques represent a rapidly advancing field within artificial intelligence, gaining significant prominence in the detection and analysis of various medical conditions through the analysis of medical data. This study presents a systematic literature review (SLR) focused on deep learning methods for the detection and analysis of multiple sclerosis (MS) using magnetic resonance imaging (MRI). The initial search identified 401 articles, which were rigorously screened, a selection of 82 highly relevant studies. These selected studies primarily concentrate on key areas such as multiple sclerosis, deep learning, convolutional neural networks (CNN), lesion segmentation, and classification, reflecting their alignment with the current state of the art. This review comprehensively examines diverse deep-learning approaches for MS detection and analysis, offering a valuable resource for researchers. Additionally, it presents key insights by summarizing these DL techniques for MS detection and analysis using MRI in a structured tabular format. © 2024 Elsevier Ltd

引用

共 139 条

[1] Goldenberg M.M., Multiple sclerosis review, Pharm. Ther., 37, 3, (2012)
[2] Dobson R., Giovannoni G., Multiple sclerosis–a review, Eur. J. Neurol., 26, 1, pp. 27-40, (2019)
[3] Ebers G.C., Environmental factors and multiple sclerosis, Lancet Neurol., 7, 3, pp. 268-277, (2008)
[4] Sadovnick A., Remick R., Allen J., Swartz E., Yee I., Eisen K., Farquhar R., Hashimoto S., Hooge J., Kastrukoff L., Et al., Depression and multiple sclerosis, Neurology, 46, 3, pp. 628-632, (1996)
[5] Murray T.J., Multiple Sclerosis: The History of a Disease, (2004)
[6] Weinshenker B.G., Natural history of multiple sclerosis, Ann. Neurol., 36, S1, pp. S6-S11, (1994)
[7] Chung K.K., Altmann D., Barkhof F., Miszkiel K., Brex P.A., O'Riordan J., Ebner M., Prados F., Cardoso M.J., Vercauteren T., Et al., A 30-year Clinical and Magnetic Resonance imaging observational study of multiple sclerosis and clinically isolated syndromes, Ann. Neurol., 87, 1, pp. 63-74, (2020)
[8] Metz L.M., Li D.K., Traboulsee A.L., Duquette P., Eliasziw M., Cerchiaro G., Greenfield J., Riddehough A., Yeung M., Kremenchutzky M., Et al., Trial of minocycline in a clinically isolated syndrome of multiple sclerosis, N. Engl. J. Med., 376, 22, pp. 2122-2133, (2017)
[9] Burt R.K., Balabanov R., Burman J., Sharrack B., Snowden J.A., Oliveira M.C., Fagius J., Rose J., Nelson F., Barreira A.A., Et al., Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial, Jama, 321, 2, pp. 165-174, (2019)
[10] Carlstrom K.E., Ewing E., Granqvist M., Gyllenberg A., Aeinehband S., Enoksson S.L., Checa A., Badam T.V., Huang J., Gomez-Cabrero D., Et al., Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes, Nature Commun., 10, 1, (2019)

← 1 2 3 4 5 6 7 8 9 10 →